SCHEMBL2009162

SCHEMBL2009162

OCCOCCOCCOCCOCCOCCOc1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
CASP1 P29466 1/20 0.49
SLCO1B3 Q9NPD5 1/20 0.49
SLCO1B1 Q9Y6L6 1/20 0.49
RECQL P46063 1/20 0.47
CYP2D6 P10635 1/20 0.43
LTA4H P09960 1/20 0.40
TSHR P16473 1/20 0.40
NR1I2 O75469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2007853 1.00 APP (0.53) APPL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL12568180 1.00 APP (0.53) APPL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL1097898 0.87 ALDH1A1 (0.60) L3MBTL1ALDH1A1KMT2ACYP3A4MAPK1
SCHEMBL3085759 0.85 APP (0.67) APPL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL24303208 0.85 APP (0.67) APPL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL466232 0.83 APP (0.65) APPL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL525095 0.82 CYP2D6 (0.56) L3MBTL1ALDH1A1KMT2ACYP3A4MAPK1
SCHEMBL4495041 0.81 CYP2D6 (0.52) L3MBTL1ALDH1A1KMT2ACYP3A4MAPK1
SCHEMBL25042263 0.80 TAAR1 (0.47) APPALDH1A1CYP3A4CYP2D6LTA4H
SCHEMBL12568190 0.80 KDM4E (0.49) APPALDH1A1CYP3A4SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960555-B2 Substituted pyridine ligands and related water-soluble catalysts UNIVERSITY OF MASSACHUSETTS (US) 2011-06-14 US disclosed
US-20090156767-A1 Substituted pyridine ligands and related water-soluble catalysts NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2009-06-18 US disclosed
US-20080269444-A1 PEG-Substituted Pyridine Ligands and Related Water-Soluble Catalysts EMRICK TODD S 2008-10-30 US disclosed
US-7332609-B2 PEG-substituted pyridine ligands and related water-soluble catalysts UNIVERSITY OF MASSACHUSETTS (US) 2008-02-19 US disclosed
US-20060235235-A1 PEG-substituted pyridine ligands and related water-soluble catalysts ENERGY, UNITED STATES DEPARTMENT OF 2006-10-19 US disclosed
WO-2006045070-A2 PEG-SUBSTITUTED PYRIDINE LIGANDS AND RELATED WATER-SOLUBLE CATALYSTS UNIVERSITY OF MASSACHUSETTS (US) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156767-A1 Substituted pyridine ligands and related water-soluble catalysts MDM4, M6PR, PWWP2B APP 3640/4885L3MBTL1 3791/4885ALDH1A1 2123/4885
US-20060235235-A1 PEG-substituted pyridine ligands and related water-soluble catalysts PAM, EGFR, NAPEPLD APP 2703/4885L3MBTL1 3562/4885ALDH1A1 2987/4885
US-20080269444-A1 PEG-Substituted Pyridine Ligands and Related Water-Soluble Catalysts PAM, EGFR, NAPEPLD APP 2703/4885L3MBTL1 3562/4885ALDH1A1 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.